Modulation of immune surface molecules associated with the efficacy of antiviral therapy for chronic hepatitis C virus infection
碩士 === 國立成功大學 === 醫學檢驗生物技術學系 === 94 === Hepatitis C virus (HCV) diseases threaten global human health. The current treatment for chronic HCV infection with combination regimen of pegylated interferon (IFN)-alpha and ribavirin can exert overall response rate of approximately 46-78%, which is influenc...
Main Authors: | Ya-Ling Wei, 魏雅鈴 |
---|---|
Other Authors: | Kung-Chia Young |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/74461008454444588958 |
Similar Items
-
Antiviral therapy in chronic hepatitis C virus infection
by: Irina Russu
Published: (2019-09-01) -
Antiviral therapy should be selected for patients in the immune-tolerant phase of chronic hepatitis B virus infection
by: CHEN Xinyue
Published: (2021-06-01) -
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020-03-01) -
CHRONIC HEPATITIS B VIRUS INFECTION IN PREGNANCY: STRATEGIES OF ANTIVIRAL THERAPY
by: P. O. Bogomolov, et al.
Published: (2016-02-01) -
Features of immune response during antiviral therapy in patients with chronic hepatitis B
by: WANG Weibin, et al.
Published: (2016-10-01)